This message was sent to ##Email##
To advertise in this publication please click here
|
|
|
.SOCIETY NEWS
Call for AST Board Nominations
AST
The AST is now accepting nominations for its 2021 Board of Directors. If you are interested in joining the AST Board, or know someone who is, we encourage you to submit your nomination. Learn more about the election process here.
|
|
The 2020 COP Donation Derby is Here
AST
We just launched the 2020 COP giving contest: The Donation Derby. Watch this race, as the COPs compete for two prizes and fundraise for their upcoming initiatives. All donations made by COP members until the end of the year will count toward this contest, so be sure to check it out today.
|
|
FAST Applications Open
AST
The Fellow of the American Society of Transplantation (FAST) designation application is now open to all members who meet the eligibility criteria. Instructions for the application can be found here. The deadline to apply is January 19, 2021. Don't miss out on joining this prestigious program and be recognized for your contributions to transplantation.
|
|
|
|
 |
|
Now you can see the different ways that different formulations are released and absorbed in the gastrointestinal system. You’ll also have the opportunity to explore comparative pharmacokinetic results in rapid metabolizers, efficacy data over 2 years, and safety information.
|
|
ONC 21st Cures Act and the CMS Patient Protection and Affordable Cares Act
AST
Two Acts were published in May 2020, the HHS Office of the National Coordinator for Health Information Technology (ONC) 21st Cures Act, and the CMS Patient Protection and Affordable Cares Act, which will soon mandate sharing of all chart notes with patients. Many institutions have been talking about how to best address these changes, which are set to go into effect on November 2, 2020. Transplant is unique in that our records may often reference two patients- the recipient and the organ donor. In pre-transplant, sensitive information may be communicated related to eligibility. The AST will be exploring opportunities to create education around best practices in this area.
|
|
Introducing the Living Donor Circle of Excellence
AST
The AST is proud to introduce the Living Donor Circle of Excellence program! The vision for this program was inspired by the need to increase living organ donation by removing financial barriers donors sometimes encounter. Today, many employers do not offer any kind of compensation to an employee recovering from donating an organ. The Circle aims to change that. By recognizing companies who support living donation through providing salary support post-surgery, the AST envisions more people will consider this altruistic act.
|
|
COVID-19 and Transplantation: AJT Articles
AST
In the interest of facilitating patient care and advancing science and ensuring that accurate knowledge and experience is available to all during this current time of crisis, AJT has been expediting review of all papers dealing with COVID-19, as well as making them free to access for all.
|
|
|
|
 |
|
- RELiZORB mimics the function of pancreatic lipase and delivers absorbable fats to your patients.
- Indicated for use in pediatric patients (ages 5 years and above) and adult patients to hydrolyze fats in enteral formula.
Learn more at relizorb.com REL20-310
|
|
AST Research Network
AST
The AST Research Network is now accepting applications for its annual career development grants cycle! The purpose of these grants is to foster the training of early career investigators who have the potential to contribute to transplant science/immunobiology and/or treatment of transplant recipients. The grants encourage continued commitment of high-quality applicants to their careers in transplantation. Applications are accepted in basic, clinical, and translational research.
|
|
|
|
.UPCOMING EDUCATION EVENTS
| |
Promoted by Veloxis Pharmaceuticals
 Over the long-term, graft survival may be impacted by factors such as declining adherence, which may be affected by complex dosing regimens and neurotoxicities. Studies show a direct correlation between rejection losses and nonadherence, which is also proven to increase over time. Review 2-year published data and see the results achieved at 2 years in de novo kidney transplant patients.
See the data
|
|
|
.TRANSPLANT NEWS
COVID-19 in Transplant Recipients: The Spanish Experience
American Journal of Transplantation
We report the nationwide experience with solid organ transplant (SOT) and hematopoietic stem cell transplant (HSCT) recipients diagnosed with coronavirus disease 2019 (COVID‐19) in Spain until 13 July 2020.
|
|
|
Labs@HOME is a mobile phlebotomy in-home blood draw service to aid in specimen collection directly from a patient's home. Clinicians can order and customize a number of infectious disease and transplant-relatedtesting remotely
|
|
|
|
|
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
Global Transplantation COVID Report March 2020
Transplantation
As during times of war, the challenges of the coronavirus crisis change our views in almost any aspect.
Transplant patients and those with end-stage organ failure are in a particular vulnerable position. Elective surgeries including live donor transplant procedures have paused in many countries. Deceased donor transplants, where the procedure is established, continue in some countries, albeit with modified donor and recipient criteria, in an attempt to reduce the risk of COVID transmission or an infection after transplantation. Those who are immunocompromised are probably at increased risk of severe disease, though the role of immunosuppression is debated and uncertain.
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
